THU0098 Long-term effects of rituximab on B-cell counts and autoantibody production in rheumatoid arthritis: Use of high-sensitivity flow-cytometry for more sensitive assessment of B-cell depletion

Abstract

BackgroundRituximab (RTX) is a B-cell depleting antibody widely used to treat rheumatoid arthritis (RA). Responses to RTX are in close correlation with the efficacy of B-cell depletion. Therefore the determination...